EXTROVIS
V.Prasanth Kumar has a Master's degree in Pharmaceutics from Birla Institute of Technology and Science, Pilani. They have held key roles in portfolio management in various pharmaceutical companies such as EXTROVIS, Biocon, Dr. Reddy's Laboratories, and Glenmark Pharmaceuticals. In these positions, they have managed portfolios in API, formulations, and various markets like the US, EU, and emerging markets. Their expertise lies in new product selection and business strategy within the pharmaceutical industry.
This person is not in any offices
EXTROVIS
Extrovis is a fully integrated global pharmaceutical company with strong portfolio offering, comprising of Active Pharmaceutical Ingredients (APIs), Finished dosage forms (FDF) & Custom Pharmaceutical Services. Based in Switzerland, with global presence in North America, India and South America, we are supported by strong network to deliver products across geographies. Our state-of-the-art manufacturing facilities and R&D centers comply with highest international quality standards with accreditions from the USFDA, PMDA, EU and other global regulatory bodies. Our contributions in the area of education and health to financially under privileged reinforces our social commitment. Our mission is to become a reliable partner by offering high quality APIs, FDFs, custom pharmaceutical services and delivering value to our customers, stake holders and patients. Backed by our EXTROrdinary VISion, we have our eyes set on becoming a leading pharmaceutical company in the world.